| Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response (NCT04577482) | AbbVie | 2020-10-07 |
| A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis (NCT04574492) | AbbVie | 2020-10-07 |
| A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML) (NCT04509622) | AbbVie | 2020-10-05 |
| Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) (NCT04524611) | AbbVie | 2020-09-30 |
| Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3) (NCT04542499) | AbbVie | 2020-09-23 |
| A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) (NCT04064827) | AbbVie | 2020-09-16 |
| Study to Evaluate the Effect of Different Warm-Up Times of Risankizumab Autoinjector (AI) on the Injection Pain Experiences in Healthy Volunteers (NCT05274087) | AbbVie | 2020-09-15 |
| Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome (NCT04401748) | AbbVie | 2020-09-10 |
| Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI) (NCT04295538) | AbbVie | 2020-09-06 |
| Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants (NCT05274100) | AbbVie | 2020-09-01 |
| Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis (NCT04468984) | AbbVie | 2020-08-31 |
| RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (NCT04514653) | AbbVie | 2020-08-25 |
| Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants (NCT04492020) | AbbVie | 2020-08-21 |
| Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain (NCT04333576) | AbbVie | 2020-08-10 |
| Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis (NCT04433442) | AbbVie | 2020-08-04 |
| A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State (NCT04451772) | AbbVie | 2020-07-27 |
| Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia (NCT04403763) | AbbVie | 2020-07-27 |
| Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis (NCT04451720) | AbbVie | 2020-07-20 |
| A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms (NCT04435600) | AbbVie | 2020-07-14 |
| A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms (NCT04430855) | AbbVie | 2020-07-14 |
| A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression (NCT04274907) | AbbVie | 2020-06-30 |
| Cariprazine Pediatric ASD PK Study (NCT04382885) | AbbVie | 2020-06-26 |
| A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine (NCT04437433) | AbbVie | 2020-06-18 |
| A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT04285580) | AbbVie | 2020-06-11 |
| Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease (NCT04379050) | AbbVie | 2020-06-08 |
| Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury (NCT04375397) | AbbVie | 2020-06-06 |
| First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors (NCT04417465) | AbbVie | 2020-06-03 |
| Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis (NCT04352309) | AbbVie | 2020-05-29 |
| A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease (NCT04254783) | AbbVie | 2020-05-27 |
| A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers (NCT04366973) | AbbVie | 2020-05-26 |
| A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy (NCT04274933) | AbbVie | 2020-05-21 |
| A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma (NCT04178902) | AbbVie | 2020-05-19 |
| A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism (NCT04274894) | AbbVie | 2020-05-12 |
| Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer (NCT04315311) | AbbVie | 2020-05-06 |
| A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers (NCT04272203) | AbbVie | 2020-05-05 |
| Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets (NCT04340115) | AbbVie | 2020-04-24 |
| A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice (NCT04178317) | AbbVie | 2020-04-02 |
| A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy (NCT04102020) | AbbVie | 2020-03-26 |
| A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation (NCT04253314) | AbbVie | 2020-03-13 |
| An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS) (NCT05217472) | AbbVie | 2020-03-06 |
| A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease (NCT04030962) | AbbVie | 2020-03-04 |
| A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease (NCT04127695) | AbbVie | 2020-03-03 |
| A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) (NCT04161885) | AbbVie | 2020-02-26 |
| A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI) (NCT03859869) | AbbVie | 2020-02-25 |
| A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation (NCT04189627) | AbbVie | 2020-02-17 |
| A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD) (NCT04262791) | AbbVie | 2020-02-17 |
| An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer (NCT04189614) | AbbVie | 2020-02-13 |
| An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid Arthritis (NCT04267536) | AbbVie | 2020-02-06 |
| A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK) (NCT04161898) | AbbVie | 2020-02-04 |
| A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) (NCT04198415) | AbbVie | 2020-02-03 |
| A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1 (NCT04223804) | AbbVie | 2020-01-30 |
| A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures (NCT04244175) | AbbVie | 2020-01-27 |
| A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT03818542) | AbbVie | 2020-01-22 |
| A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT04196283) | AbbVie | 2020-01-22 |
| A Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Due to Suspected or Confirmed Endometriosis and the Impact on the Disease or Symptom Progression. (NCT04140175) | AbbVie | 2020-01-20 |
| Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis (NCT04195698) | AbbVie | 2020-01-15 |
| A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia (NCT03873493) | AbbVie | 2020-01-14 |
| A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece (NCT04159779) | AbbVie | 2020-01-13 |
| Flexible-Dose Trial in Early Parkinson's Disease (PD) (NCT04223193) | AbbVie | 2020-01-06 |
| A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression (NCT04209855) | AbbVie | 2019-12-31 |
| A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus (NCT04214028) | AbbVie | 2019-12-26 |
| Fixed-Dose Trial in Early Parkinson's Disease (PD) (NCT04201093) | AbbVie | 2019-12-13 |
| A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222 (NCT03969888) | AbbVie | 2019-12-11 |
| Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada (NCT04080856) | AbbVie | 2019-12-04 |
| A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis (NCT04169373) | AbbVie | 2019-11-26 |
| Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C (NCT04166058) | AbbVie | 2019-11-19 |
| A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab (NCT04102007) | AbbVie | 2019-11-12 |
| A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm (NCT04041050) | AbbVie | 2019-11-08 |
| IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia (NCT04086264) | AbbVie | 2019-11-06 |
| A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation (NCT04138199) | AbbVie | 2019-11-01 |
| A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (NCT03924947) | AbbVie | 2019-10-23 |
| BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle Prominence (NCT04073303) | AbbVie | 2019-08-29 |
| A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy (NCT03941964) | AbbVie | 2019-08-15 |
| Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome (NCT03951077) | AbbVie | 2019-08-12 |
| A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study) (NCT03987958) | AbbVie | 2019-08-08 |
| A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies (NCT03557619) | AbbVie | 2019-07-30 |
| A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) (NCT03978520) | AbbVie | 2019-07-25 |
| Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis (NCT03982394) | AbbVie | 2019-07-01 |
| A Study of Intravenously (IV) Infused or Subcutaneously (SC) Injected Risankizumab in Healthy Adult Participants in China (NCT05268068) | AbbVie | 2019-06-27 |
| Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea (NCT03925441) | AbbVie | 2019-06-25 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis (NCT03725007) | AbbVie | 2019-06-24 |
| A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma (NCT03933735) | AbbVie | 2019-06-24 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis (NCT03922607) | AbbVie | 2019-06-11 |
| A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (NCT03926169) | AbbVie | 2019-06-03 |
| Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy (NCT03999801) | AbbVie | 2019-05-31 |
| A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder (NCT03924323) | AbbVie | 2019-05-30 |
| A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (NCT03893955) | AbbVie | 2019-05-21 |
| A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib (NCT03823378) | AbbVie | 2019-05-13 |
| A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis (NCT03875482) | AbbVie | 2019-05-13 |
| Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa (NCT03894956) | AbbVie | 2019-05-02 |
| A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD) (NCT03781167) | AbbVie | 2019-04-29 |
| A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy (NCT03785184) | AbbVie | 2019-04-29 |
| A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (NCT03886220) | AbbVie | 2019-04-12 |
| A Study to Evaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adult Participants (NCT05283681) | AbbVie | 2019-04-02 |
| Long-term Safety and Efficacy Extension Trial of Bimatoprost SR (NCT03891446) | AbbVie | 2019-03-27 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA) (NCT03823391) | AbbVie | 2019-03-27 |
| A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy (NCT03695185) | AbbVie | 2019-03-26 |
| A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (NCT03675308) | AbbVie | 2019-03-25 |
| An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD) (NCT03712787) | AbbVie | 2019-03-22 |
| A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies (NCT03797261) | AbbVie | 2019-03-18 |